Aspire Biopharma Holdings (ASBP) Share-based Compensation (2025 - 2026)
Aspire Biopharma Holdings (ASBP) posted quarterly Share-based Compensation of $13406.0 for Q1 2026, down 100.0% year-over-year from $14131.2 billion in Q1 2025, and up 142.9% quarter-over-quarter from -$31250.0 in Q4 2025.
Aspire Biopharma Holdings (ASBP) Share-based Compensation (2025 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has reported Share-based Compensation for 2 consecutive years, with $13406.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation fell 100.0% year-over-year to $13406.0; the TTM figure through Mar 2026 stood at -$14131.2 billion (changed N/A YoY), while the FY2025 annual figure was $14.1 million, changed N/A from the prior year.
- Share-based Compensation rose to $13406.0 in Q1 2026 per ASBP's latest filing, from -$31250.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $14131.2 billion in Q1 2025 and bottomed at -$14131.2 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Aspire Biopharma Holdings | 8.30 Mn | -3.86 Mn | -30,086.00 | 157,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 157,500.00 |
| Jun 30, 2026 | 157,500.00 |
| Mar 31, 2026 | 13,406.00 |
| Mar 31, 2026 | 13,406.00 |
| Dec 31, 2025 | -31,250.00 |
| Dec 31, 2025 | -31,250.00 |
| Jun 30, 2025 | -14,131.24 Bn |
| Jun 30, 2025 | -14,131.24 Bn |
| Mar 31, 2025 | 14,131.25 Bn |
| Mar 31, 2025 | 14,131.25 Bn |